Ventilator

New ‘Negative Pressure Scavenger Kit’ Helps Hospitals Manage Infectious Particles When Treating Patients with COVID-19, Supports Non-Profits Supporting COVID-19 Front-Line Clinicians

Wednesday, August 12, 2020 - 1:45pm

All profits from the kits will be distributed to non-profit organizations supporting front-line clinicians fighting the COVID-19 pandemic.

Key Points: 
  • All profits from the kits will be distributed to non-profit organizations supporting front-line clinicians fighting the COVID-19 pandemic.
  • View the full release here: https://www.businesswire.com/news/home/20200812005383/en/
    Patient treated with Vapotherm high velocity therapy while using the FELIX-1 negative pressure scavenger kit (Photo: Business Wire)
    The FELIX-1 negative pressure scavenger kit is a preassembled tool compatible with high velocity therapy, an advanced form of high flow nasal cannula increasingly used by clinicians in supporting the respiratory needs of COVID-19 patients.
  • The company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders.
  • Vapotherm high velocity therapy is mask-free noninvasive ventilatory support and is a front-line tool for relieving respiratory distressincluding hypercapnia, hypoxemia, and dyspnea.

Worldwide Medical Ventilators Industry to 2024 - Impact of the COVID-19 Pandemic

Tuesday, August 11, 2020 - 4:00pm

DUBLIN, Aug. 11, 2020 /PRNewswire/ -- The "Global Medical Ventilators Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 11, 2020 /PRNewswire/ -- The "Global Medical Ventilators Market" report has been added to ResearchAndMarkets.com's offering.
  • This report examines the current and future market potential of medical ventilators.
  • The report also covers market projections to 2024 and market rank for key market players.
  • The report details the market share of medical ventilators based on types of ventilation, types of products, and end-users.

MedAcuity Partners with The Ventilator Project in Advisory Role

Tuesday, August 11, 2020 - 3:12pm

MedAcuity will act in a pro bono advisory role to support their mission of developing a safer and more affordable ventilator to address the worldwide shortage exposed by the COVID-19 pandemic.

Key Points: 
  • MedAcuity will act in a pro bono advisory role to support their mission of developing a safer and more affordable ventilator to address the worldwide shortage exposed by the COVID-19 pandemic.
  • Through tireless engineering efforts, "AIRA" was createdan easily scalable ventilator that uses materials sourced from outside the biomedical supply chain.
  • "When we heard what The Ventilator Project was aiming to do, we knew immediately that we wanted to get involved," said Susan Jones, engineering manager at MedAcuity.
  • At this time, The Ventilator Project concluded a rigorous three-week testing phase to ensure that the ventilator meets all the required safety specifications.

Festo App Aids Operation of New Emergency Equipment for COVID-19 Care in Field Hospitals

Tuesday, August 11, 2020 - 3:00pm

The two companies developed the Virus Fighters Handbook , an information delivery app for field hospitals, where newly designed emergency ventilators and other new emergency devices are being set up, operated, and maintained for the first time by ad hoc personnel.

Key Points: 
  • The two companies developed the Virus Fighters Handbook , an information delivery app for field hospitals, where newly designed emergency ventilators and other new emergency devices are being set up, operated, and maintained for the first time by ad hoc personnel.
  • The app places vital information at the fingertips of care providers about the new machines and how they are applied in COVID-19 treatment.
  • Category requirements included the ability to produce the equipment anywhere in the world using 3D printing or other fast manufacturing processes.
  • The Fraunhofer team, which specializes in the development of educational material in the field of medical technology, supplied the training content.

Global Medical Ventilators Market (2018 to 2024) - Featuring Getinge, Hamilton Medical & Koninklijke Philips Among Others - ResearchAndMarkets.com

Tuesday, August 11, 2020 - 2:13pm

Medical ventilators supply oxygen to the lungs and remove carbon dioxide from the body.

Key Points: 
  • Medical ventilators supply oxygen to the lungs and remove carbon dioxide from the body.
  • Some people may have a condition that requires long-term or even permanent use of a ventilator.
  • The increasing prevalence of respiratory diseases due to urbanization and growing pollution levels, high prevalence of tobacco smoking, changing lifestyles (such as lack of exercise), a rapidly expanding geriatric population are pushing the growth of the global ventilators market.
  • Also, pandemics like 2019 Novel Coronavirus (COVID-19) are driving the global demand for ventilators.

Protech Announces Execution of an LOI to Acquire a Profitable Respiratory Care Business in the Midwestern U.S.

Tuesday, August 11, 2020 - 1:00pm

The target company is a leader in the respiratory home care services industry in the Midwestern United States.

Key Points: 
  • The target company is a leader in the respiratory home care services industry in the Midwestern United States.
  • This program makes up just over one third of the targets overall revenue and is also the fastest growing segment of its business.
  • Protech feels strongly about bolstering its non-invasive ventilator volume as a percentage of its product mix given the strong market fundamentals.
  • We are thrilled to have executed an LOI to add a substantial Midwest based respiratory care provider to the Protech family, said Greg Crawford, Chairman and CEO of Protech.

Noninvasive Ventilator Obtains EUA from the FDA for At-Home Use for the Treatment of COVID-19

Monday, August 10, 2020 - 2:00pm

Nanotronics Health, LLC, a subsidiary of Nanotronics, announced today that it has obtained Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for its non-invasive ventilator, nHale, for at-home use.

Key Points: 
  • Nanotronics Health, LLC, a subsidiary of Nanotronics, announced today that it has obtained Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for its non-invasive ventilator, nHale, for at-home use.
  • Nanotronics Health, LLC, also received authorization for the nHale to be used with supplemental oxygen under a doctors prescription.
  • nHale is accessible to patients at a fraction of the cost of other noninvasive ventilators.
  • Our first product, nHale, a non-invasive ventilator, was conceived, built, and obtained Emergency Use Authorization by the FDA within 90 days to treat patients suffering from COVID-19.

Pluristem Expands its COVID-19 Program to Europe, Receives PEI Clearance to Commence Phase II Study in Germany

Monday, August 10, 2020 - 12:00pm

Forty (40) patients hospitalized with severe cases of COVID-19 complicated by Acute Respiratory Distress Syndrome (ARDS) will be enrolled in the study.

Key Points: 
  • Forty (40) patients hospitalized with severe cases of COVID-19 complicated by Acute Respiratory Distress Syndrome (ARDS) will be enrolled in the study.
  • The primary efficacy endpoint of the study is the number of ventilator free days during the 28 days from day 1 through day 28 of the study.
  • Based on our discussions with the PEI, this will be a standalone study, with the active arm compared to the current standard of care.
  • In addition to this study in Germany, Pluristem is currently conducting a Phase II COVID-19 trial in the U.S. which will enroll 140 patients.

Ventilators - Global Market Analysis and Forecast Model 2015-2030 (COVID-19 Market Impact)

Thursday, August 6, 2020 - 9:15pm

DUBLIN, Aug. 6, 2020 /PRNewswire/ -- The "Ventilators (Anesthesia and Respiratory Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 6, 2020 /PRNewswire/ -- The "Ventilators (Anesthesia and Respiratory Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.
  • The model discusses in detail the impact of COVID-19 on Ventilators Market for the year 2020 and beyond.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ventilators market in the future.
  • Track device sales in the global and country-specific ventilators market from 2015-2030.

Vapotherm to Present at the Canaccord Genuity 40th Annual Growth Conference

Thursday, August 6, 2020 - 9:01pm

Vapotherm is scheduled to present at 10:30 am Eastern Time.

Key Points: 
  • Vapotherm is scheduled to present at 10:30 am Eastern Time.
  • Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA.
  • Vapotherm high velocity therapy is mask-free noninvasive ventilatory support and is a front-line tool for relieving respiratory distressincluding hypercapnia, hypoxemia, and dyspnea.
  • Website Information Vapotherm routinely posts important information for investors on the Investor Relations section of its website, http://investors.vapotherm.com/ .